by University of Southern California Credit: Pixabay/CC0 Public Domain Two stories dominated Alzheimer’s news this year: The FDA’s approval of Leqembi, the first drug to slow progression of the disease, and a surprising study showing that mild cognitive impairment is wildly underdiagnosed. “For mild cognitive impairment, or MCI, caused by Alzheimer’s disease, the earlier you treat...
